• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

FGFR4基因多态性与TP53基因突变联合对膀胱癌预后的影响

Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis.

作者信息

Yang Y C, Lu M L, Rao J Y, Wallerand H, Cai L, Cao W, Pantuck A, Dalbagni G, Reuter V, Figlin R A, Belldegrun A, Cordon-Cardo C, Zhang Z F

机构信息

Department of Epidemiology, UCLA School of Public Health and Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, USA.

出版信息

Br J Cancer. 2006 Dec 4;95(11):1455-8. doi: 10.1038/sj.bjc.6603456. Epub 2006 Nov 7.

DOI:10.1038/sj.bjc.6603456
PMID:17088904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2360734/
Abstract

The impact of the fibroblast growth factor receptor 4 (FGFR4) Gly388Arg polymorphism on bladder cancer is unknown. We found no clear correlations between the FGFR4 genotype and risk of bladder cancer or pathological parameters. Neither the polymorphism nor TP53 mutation status was an independent predictor of prognosis, but they might act jointly on the disease-specific survival of patients.

摘要

成纤维细胞生长因子受体4（FGFR4）Gly388Arg多态性对膀胱癌的影响尚不清楚。我们发现FGFR4基因型与膀胱癌风险或病理参数之间没有明显的相关性。该多态性和TP53突变状态均不是预后的独立预测因素，但它们可能共同影响患者的疾病特异性生存。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aea/2360734/6763a9d8d2aa/95-6603456f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aea/2360734/345f11f4df0e/95-6603456f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aea/2360734/6763a9d8d2aa/95-6603456f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aea/2360734/345f11f4df0e/95-6603456f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aea/2360734/6763a9d8d2aa/95-6603456f2.jpg

相似文献

1
Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis.FGFR4基因多态性与TP53基因突变联合对膀胱癌预后的影响
Br J Cancer. 2006 Dec 4;95(11):1455-8. doi: 10.1038/sj.bjc.6603456. Epub 2006 Nov 7.
2
FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma.FGFR4 多态性、TP53 突变及其组合是口腔鳞状细胞癌的预后因素。
Oncol Rep. 2010 Mar;23(3):739-44.
3
FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung.FGFR4基因Gly388Arg多态性可能通过调节正常肺组织的转录谱来影响肺癌患者的临床分期。
Int J Cancer. 2009 Jun 15;124(12):2880-5. doi: 10.1002/ijc.24302.
4
The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.成纤维细胞生长因子受体 4 Arg388 等位基因与胃癌进展相关。
Ann Surg Oncol. 2010 Dec;17(12):3354-61. doi: 10.1245/s10434-010-1323-6. Epub 2010 Sep 16.
5
Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis.关于FGFR4 Gly388Arg多态性与肺癌预后关系的进一步观察
Br J Cancer. 2007 Jun 18;96(12):1904-7. doi: 10.1038/sj.bjc.6603816. Epub 2007 May 22.
6
Gender-Specific Association Between FGFR4 Gly388Arg Gene Variants and Hypertension.FGFR4 Gly388Arg基因变异与高血压之间的性别特异性关联
Genet Test Mol Biomarkers. 2017 Jul;21(7):422-427. doi: 10.1089/gtmb.2016.0320. Epub 2017 Jun 26.
7
FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.FGFR4基因第388位密码子的精氨酸等位基因与原发性乳腺癌辅助治疗的耐药性相关。
J Clin Oncol. 2006 Aug 10;24(23):3747-55. doi: 10.1200/JCO.2005.04.8587. Epub 2006 Jul 5.
8
Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.在日本人群中，成纤维细胞生长因子受体4的多态性与前列腺癌和良性前列腺增生的发生以及前列腺癌的进展相关。
Int J Cancer. 2008 Dec 1;123(11):2574-9. doi: 10.1002/ijc.23578.
9
Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.FGFR4 Gly388Arg 多态性作为癌症预后因素的荟萃和 pooled 分析。
Eur J Cancer Prev. 2011 Jul;20(4):340-7. doi: 10.1097/CEJ.0b013e3283457274.
10
A polymorphism in HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancer.HDM2基因多态性（SNP309）与浅表性肿瘤的早期发病、TP53突变以及浸润性膀胱癌的不良预后相关。
Clin Cancer Res. 2007 Jun 1;13(11):3215-20. doi: 10.1158/1078-0432.CCR-07-0013.

引用本文的文献

1
Gly388Arg Polymorphism Reveals a Poor Prognosis, Especially in Asian Cancer Patients: A Meta-Analysis.Gly388Arg多态性显示预后不良，尤其是在亚洲癌症患者中：一项荟萃分析。
Front Oncol. 2021 Oct 19;11:762528. doi: 10.3389/fonc.2021.762528. eCollection 2021.
2
Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma.成纤维细胞生长因子受体 4 基因变异与尿路上皮细胞癌临床病理严重程度的关系。
Int J Environ Res Public Health. 2019 Dec 23;17(1):129. doi: 10.3390/ijerph17010129.
3
The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction.

本文引用的文献

1
FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients.FGFR4基因的Arg388等位基因与肿瘤厚度相关，FGFR4蛋白表达与黑色素瘤患者的生存率相关。
Br J Cancer. 2006 Jun 19;94(12):1879-86. doi: 10.1038/sj.bjc.6603181. Epub 2006 May 23.
2
Functional FGFR4 Gly388Arg polymorphism predicts prognosis in lung adenocarcinoma patients.功能性FGFR4 Gly388Arg基因多态性可预测肺腺癌患者的预后。
J Clin Oncol. 2005 Oct 10;23(29):7307-11. doi: 10.1200/JCO.2005.17.350. Epub 2005 Aug 1.
3
FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer.
FGFR4-388arg 变异通过诱导 N-钙黏蛋白促进肺癌进展。
Sci Rep. 2018 Feb 5;8(1):2394. doi: 10.1038/s41598-018-20570-3.
4
Is fibroblast growth factor receptor 4 a suitable target of cancer therapy?成纤维细胞生长因子受体 4 是否是癌症治疗的合适靶点？
Curr Pharm Des. 2014;20(17):2881-98. doi: 10.2174/13816128113199990594.
5
Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients.中国胃癌患者成纤维细胞生长因子受体 4 Gly388Arg 多态性。
World J Gastroenterol. 2013 Jul 28;19(28):4568-75. doi: 10.3748/wjg.v19.i28.4568.
6
When mutants gain new powers: news from the mutant p53 field.当突变体获得新能力时：来自突变型p53领域的消息。
Nat Rev Cancer. 2009 Oct;9(10):701-13. doi: 10.1038/nrc2693. Epub 2009 Aug 20.
7
Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis.关于FGFR4 Gly388Arg多态性与肺癌预后关系的进一步观察
Br J Cancer. 2007 Jun 18;96(12):1904-7. doi: 10.1038/sj.bjc.6603816. Epub 2007 May 22.
FGFR4基因Gly388Arg多态性与乳腺癌和结直肠癌的预后
Oncol Rep. 2005 Aug;14(2):415-9.
4
The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression.成纤维细胞生长因子受体-4的精氨酸388等位基因与前列腺癌的发生和进展相关。
Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6169-78. doi: 10.1158/1078-0432.CCR-04-0408.
5
Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma.FGFR4基因第388位精氨酸等位基因与头颈部鳞状细胞癌的关系。
Int J Cancer. 2004 Aug 20;111(2):213-7. doi: 10.1002/ijc.20204.
6
FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma.FGFR3和P53是尿路上皮细胞癌发病机制中不同遗传途径的特征。
Cancer Res. 2004 Mar 15;64(6):1911-4. doi: 10.1158/0008-5472.can-03-2421.
7
G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis.FGFR4基因的G388R突变与乳腺癌预后无关。
Br J Cancer. 2004 Jan 12;90(1):189-93. doi: 10.1038/sj.bjc.6601450.
8
Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma.成纤维细胞生长因子受体4第388位密码子的单核苷酸多态性与高级别软组织肉瘤的预后相关。
Cancer. 2003 Nov 15;98(10):2245-50. doi: 10.1002/cncr.11778.
9
The fibroblast growth factor receptor gene Arg388 allele is not associated with early lymph node metastasis of breast cancer.成纤维细胞生长因子受体基因的Arg388等位基因与乳腺癌早期淋巴结转移无关。
Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):582-3.
10
Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.癌症进展和肿瘤细胞迁移与FGFR4 Arg(388)等位基因相关。
Cancer Res. 2002 Feb 1;62(3):840-7.